Fact check: Drugmaker Gilead Sciences claimed rights to a possible COVID-19 treatment

Dr. Anthony Fauci told Golden State Warriors star Stephen Curry on Thursday that the United States will not be able to get "back to some degree of normality" until the country starts seeing a decline in confirmed coronavirus cases. (March 26) AP Domestic

The claim: Gilead Sciences received special protective status from the FDA for a drug that may effectively treat COVID-19

On Tuesday, the website Common Dreams published an article lambasting the Food and Drug Administration’s decision to provide pharmaceutical company Gilead Sciences “orphan” drug status for its antiviral drug remdesivir. The drug is among several potential treatments for the novel coronavirus.

The article relies heavily on a report in the Intercept, which reported on the story Monday night after the FDA approved special status for the drug that afternoon.

The Common Dreams article also includes tweets from Sen. Bernie Sanders, I-Vt., and the advocacy group Social Security Works criticizing the move.

Common Dreams is a nonprofit website based in Portland, Maine. Its stories often aggregate reporting and commentary from prominent figures in progressive American politics. The site also frequently republishes state propaganda from leftist governments, especially Telesur, the Latin American news network with ties to the Cuban, Nicaraguan and Venezuelan governments.

Orphan drug status and Gilead’s antiviral treatment

Initially developed as a potential treatment for the Ebola and Marburg viruses, Gilead Sciences developed remdesivir alongside the Department of Defense, later deploying the drug during the 2014-16 Ebola epidemic in west Africa. The antirviral proved effective against a broad range of viruses, though it was not yet considered to be a perfect treatment for any specific disease.

Gilead had previously faced pressure to find ways to monetize antiviral drugs like remdesivir from investors prior to its application to the FDA, according to a separate report from The Intercept.

On Sunday, Gilead announced  that it would stop allowing access to remdesivir for patients while it transitioned from providing individual compassionate use requests to an expanded access program. 

"During this transition period, we are unable to accept new individual compassionate use requests due to an overwhelming demand over the last several days," the statement said. 

On Monday afternoon, the FDA designated remdesivir as an “orphan” status drug.

"Orphan" drug status is a designation for medicines that treat conditions that would otherwise be unprofitable for companies to invest research and development resources in. The status provides certain government benefits, including exclusive rights to distribution, that ostensibly incentivize companies to address lesser-known diseases.

The FDA will provide orphan status to any medication that treats a disease that afflicts fewer than 200,000 people in the United States. However, the criteria for qualification says that approval “is defined as the number of persons in the United States who have been diagnosed as having the disease or condition at the time of the submission of the request for orphan-drug designation.”

At the time of Gilead’s submission to approve remdesivir for orphan status, there were fewer than 50,000 cases in the United States.

The drugmaker received significant criticism after it received approval for orphan drug status, including from Sanders. "We will not tolerate profiteering. Any treatment or vaccine must be made free for all," the senator and presidential candidate tweeted.

On Wednesday, Gilead issued another statement,saying that it had withdrawn its request for orphan status for remdesivir.

“Gilead is confident that it can maintain an expedited timeline in seeking regulatory review of remdesivir, without the orphan drug designation,” it read.

Our ruling: True

The claim that pharmaceutical company Gilead Sciences requested and received approval for a special status for a potential COVID-19 treatment is TRUE based on our research.

While it is still unclear whether remdesivir is an effective antiviral treatment against the novel coronavirus, trials to determine that will now proceed without special FDA status for the drug.

Our sources: 

Source: https://www.usatoday.com/story/news/factcheck/2020/03/27/fact-check-coronavirus-gilead-sciences-received-withdrew-fda-orphan-status-remdesivir/2922115001/

News Related


Trump’s ‘mission accomplished’ moment is premature and deadly. We have not defeated COVID.

Desperate for crowds and adoration, Trump has put his most fervent supporters at risk of getting a deadly disease. Future historians will be astonished. Read more »

NFLPA president JC Tretter says NFL is putting season, players at risk with its coronavirus approach

NFL Players Association president JC Tretter said Tuesday the NFL is putting the 2020 season at risk with its coronavirus approach, calling on the league to better “prioritize player safety.” “Like many other... Read more »

Brazilian President Jair Bolsonaro says he tested positive for the coronavirus

RIO DE JANEIRO (AP) — Brazil’s President Jair Bolsonaro says he has tested positive for COVID-19 after months of downplaying the virus’ severity. Bolsonaro confirmed the test results while wearing a mask and... Read more »

Venice Film Festival forges ahead amid COVID-19 pandemic with reduced lineup

The show will go on for the Venice Film Festival in September, but with a few modifications due to the COVID-19 pandemic. Organizers said Tuesday that they are pushing forward with plans for... Read more »

Amtrak offers buy-one, get-one promotion on its sleeper trains amid COVID-19 — with a catch

Amtrak wants you to have sweet dreams the next time you travel — so much so that it’s sweetening the deal on its sleeper “roomettes.” The rail service is offering a buy-one-get-one-free discount... Read more »

Florida teen treated with hydroxychloroquine at home before dying of COVID-19, report says

FORT MEYERS, Fla. – The family of a 17-year-old Florida girl who died last month from COVID-19 treated her symptoms at home for nearly a week before taking her to a hospital, a... Read more »

Mookie Betts worried MLB coronavirus testing woes could prevent him from ever playing for Dodgers

During nearly four months away from the game, Mookie Betts said he “stayed away from baseball to keep myself sane.” It’s not hard to understand why. The 2018 American League Most Valuable Player... Read more »

Tom Hanks doesn’t get ‘how common sense has somehow been put into question’ with coronavirus

Read more »

Can Gov. DeSantis force Florida schools to reopen amid the coronavirus pandemic? Some school leaders seem doubtful.

PALM BEACH, Fla. — As concern about the state order spread online, some school leaders said: Not so fast. As Florida educators puzzle over how to start the new academic year, Gov. Ron... Read more »

Texas surpasses 200,000 coronavirus cases after 4th of July holiday weekend

AUSTIN, Texas – Texas reached 200,000 total COVID-19 cases Monday, just 17 days after crossing the 100,000 threshold, a figure that took the state nearly four months to hit. The grim milestone came... Read more »